Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
Oncology|June 20, 2019
Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1Zensho Ito, Shin Kan, Tsuuse Bito, et al.
World Journal of Gastroenterology|October 24, 2014
Production of corticotropin-releasing factor and urocortin from human monocyte-derived dendritic cells is stimulated by commensal bacteria in intestineShigeo Koido, Toshifumi Ohkusa, Shin Kan, et al.
Oncology Letters|July 17, 2018
Prognostic significance of Wilms' tumor 1 expression in patients with pancreatic ductal adenocarcinomaTomoya Kanai, Zensho Ito, Yusuke Oji, et al.
Japanese Journal of Infectious Diseases|March 22, 2013
Nested culture method improves detection of Fusobacterium from stool in patients with ulcerative colitisToyokazu Yukawa, Toshifumi Ohkusa, Tomoyoshi Shibuya, et al.
Clinical Immunology (Orlando, Fla.)|March 16, 2010
Dendritic/pancreatic carcinoma fusions for clinical use: Comparative functional analysis of healthy- versus patient-derived fusionsShigeo Koido, Eiichi Hara, Sadamu Homma, et al.
Journal for Immunotherapy of Cancer|July 31, 2025
Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a multifunctional Wilms' tumor 1 (WT1) peptide cocktail-pulsed dendritic cell vaccineShigeo Koido, Junichi Taguchi, Masamori Shimabuku, et al.
Plos One|February 23, 2019
Metagenomic analyses of the gut microbiota associated with colorectal adenomaKeisuke Saito, Shigeo Koido, Toshitaka Odamaki, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 2016
Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastomaYasuharu Akasaki, Tetsuro Kikuchi, Sadamu Homma, et al.
World Journal of Gastroenterology|October 24, 2015
Prognostic significance of plasma interleukin-6/-8 in pancreatic cancer patients receiving chemoimmunotherapyShintaro Tsukinaga, Mikio Kajihara, Kazuki Takakura, et al.
Anticancer Research|January 1, 2015
Prognostic markers for patient outcome following vaccination with multiple MHC Class I/II-restricted WT1 peptide-pulsed dendritic cells plus chemotherapy for pancreatic cancerKazuki Takakura, Shigeo Koido, Shin Kan, et al.
Pageof 15